Product information
From Health Canada
Note - The product information found within this database originates from organizations not subject to the Official Languages Act and is available in the language in which it was written and submitted to Health Canada.
Note - The market status of a product is now available in the LNHPD and identifies if a product is "marketed" or "not marketed" in Canada. Product licence holders may voluntarily provide the Natural and Non-Prescription Health Products Directorate (NNHPD) with information about whether their product is currently available to Canadian consumers. Where no information has been provided, the default status is "not marketed". The "current status" field remains unaffected and will continue to indicate the status of the product licence (i.e., active, discontinued, stop sale, cancelled, or suspended). Note that where a licence has been suspended, cancelled or under stop sale, the product cannot be legally sold in Canada.
Product licence holders - if you wish to update a product's market status, you are invited to complete the Natural Health Products Market Notification Web Form. As with all other notifications, there is no current service standard. The NNHPD will process the market status update as soon as feasible, based on its available resources. As a reminder, market notification is voluntary; therefore, a licence holder is not required to wait for the LNHPD to be updated before a licensed product is sold in Canada. As such, products that are identified in the LNHPD as "not marketed" may still be sold in Canada.
- Natural Product Number (NPN):
- 80139716
- Market status:
- Marketed
- Licence Status:
- Active
- Brand name(s):
-
AblUTIon
;
Bhui-Amla ;
Niruri - Licence holder:
- New Roots Herbal Inc.
- Dosage Form:
- Capsule
- Recommended route of administration:
-
Oral
| Sub population (Sub Pop.) | Quantity (Qty) | Frequency (Freq.) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sub Pop. | Age | Min. | Max. | UoM Footnote1 Age | Qty | Min. | Max. | UoM Qty | Freq. | Min. | Max. | UoM Freq. |
| Adults | 18 | year(s) | 1.0 | capsule | 1 | daily | ||||||
- Recommended use or purpose:
- Chanca Piedra is traditionally used in Ayurveda as a diuretic (Mutrala) to help relieve mild urinary tract infections. Chanca Piedra is traditionally used in Ayurvedic Medicine as a bitter tonic to help stimulate liver, improve digestion and stimulate appetite.
- Risk Information:
- Cautions and Warnings
- If symptoms persist or worsen, or if new symptoms develop, discontinue use and consult a health care practitioner. Consult a health care practitioner prior to use if you are trying to conceive. If you have urinary tract infection symptoms, including fever, painful urination, spasm and/or blood in urine, consult a health care practitioner prior to use. Stop use and seek medical attention immediately if you experience dizziness, confusion, muscle weakness or pain, abnormal heart beat and/or difficulty breathing.
- Contra-Indications
- Do not use if you are pregnant or breastfeeding. Do not use if you have a history of kidney stones. Do not use this product if you have kidney or liver disorder, or edema (swelling of hands, face and feet) or are taking products containing diuretics. Do not use this product if you have heart disease or if you are taking heart medications. Do not use if you have diabetes or if you are taking any medication to control blood sugar levels. Do not use if you have high or low blood pressure or if you are taking blood pressure medication.
| Medicinal ingredients | Quantity (Qty) | Extract | Potency |
|---|---|---|---|
| Phyllanthus niruri |
500.0 mg
|
10
:
1
DHE: 5000 mg Dry |
- List of non-medicinal ingredients:
-
- Hypromellose
- Magnesium stearate
- Oryza sativa (Rice) hull powder
- Purified water
- Silicon dioxide
- Date of licensing:
- 2025-03-31
- Revised date of licence:
Application information
Related information
Contact us
For technical support or if you have general questions concerning the content of this database, please contact the Natural Health Products Directorate (NHPD).